The Latest Cardiac and Vascular News
After a decade of clinical use* and more than 50,000 devices sold globally, the GORE® CARDIOFORM Septal Occluder continues a trusted legacy of safely advancing care. FLAGSTAFF, Ariz., Jan. 19, 2022 /PRNewswire/ — W. L. Gore & Associates (Gore) today announced that the GORE® CARDIOFORM Septal Occluder has achieved 10 years of clinical […]
SUZHOU, China, Jan. 19, 2022 /PRNewswire/ — Peijia Medical Limited (HKEX: 9996) is pleased to announce its strategic investment and exclusive in-licensing agreement with JenaValve Technology, Inc. Under the terms of the agreement, Peijia has made a cash and equity investment in JenaValve and will commit additional capital based upon development milestones in […]
REDWOOD CITY, Calif., Jan. 18, 2022 (GLOBE NEWSWIRE) — HeartFlow Holding, Inc., the leader in revolutionizing precision heart care, today announced the appointment of Timothy Barabe to its Board of Directors. “We are honored to have an accomplished leader like Tim join the HeartFlow Board,” said William C. Weldon, Chairman of […]
Initial three-year software-as-a-service agreement will enable Stanford Health Care to deploy AI-powered cardiac MRI scans with Siemens Healthineers and GE Healthcare MRI machines AI technology produces diagnostic-level images quickly and efficiently while also increasing CMR throughput PALO ALTO, Calif.–(BUSINESS WIRE)–HeartVista, a pioneer in AI-powered MRI solutions, today announced that it […]
Live Case will be Broadcasted Today at 11:00am ET TEL AVIV, Israel, Jan. 18, 2022 (GLOBE NEWSWIRE) — InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for prevention of stroke caused by Carotid Artery Disease (CAD), today announced that a live case demonstration featuring CGuard™ […]
Findings published in American Heart Association’s Circulation: Cardiovascular Interventions CLEVELAND – Findings from a first-of-its-kind study conducted at University Hospitals (UH) Harrington Heart & Vascular Institute showed a novel system-wide interdisciplinary team assembled to evaluate alternative treatments to major amputation improved outcomes for patients with Critical Limb-Threatening Ischemia (CLTI). […]
Artivion to Host Investor & Analyst Day on March 23, 2022 ATLANTA, Jan. 18, 2022 /PRNewswire/ — CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it was renaming and rebranding itself to Artivion, Inc., effective immediately. Derived from the words “aorta”, “innovation”, and […]
Preliminary Full Year 2021 Product Sales were approximately $40.1 million, including core non-COVID-19 sales growth of approximately 13% from 2020. Cumulative CytoSorb treatments surpassed 162,000. MONMOUTH JUNCTION, N.J., Jan. 18, 2022 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood […]
VANCOUVER and MINNEAPOLIS, Jan. 18, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced the publication of a case series in the journal Cardiovascular Revascularization Medicine describing successful uses of the Neovasc Reducer™ (“Reducer”) under a compassionate use protocol in the United States. The patients were treated under the care […]
January 18, 2021 New capabilities on Philips Image Guided Therapy Mobile C-arm System – Zenition – and collaboration with Cydar offer the latest advances in endovascular treatment Partnership adds new innovations to the Zenition platform to elevate the clinical experience, enhance workflow efficiency and help improve patient outcomes Amsterdam, the Netherlands […]
